Citation: Lei ZHANG, Zhuo CHEN. Research Progress of Structure Based Antitumor Drug Design[J]. Chinese Journal of Structural Chemistry, ;2020, 39(12): 2085-2090. doi: 10.14102/j.cnki.0254–5861.2011–3036 shu

Research Progress of Structure Based Antitumor Drug Design

Lei ZHANG ^{a, b} ,
Zhuo CHEN ^{a, b,,}

a.
State Key Laboratory of Structural Chemistry, Fujian Institute of Research on the Structure of Matter, Chinese Academy of Sciences, Fuzhou 350002, China
b.
University of Chinese Academy of Sciences, Beijing 100049, China

Corresponding author: Zhuo CHEN, zchen@fjirsm.ac.cn
Received Date: 11 November 2020
Accepted Date: 20 November 2020

Fund Project: the National Natural Science Foundation of China 21877113the National Natural Science Foundation of China 81572944the National Natural Science Foundation of China 31300650Natural Science Foundation of Fujian Province 2020I0036Natural Science Foundation of Fujian Province 2019Y9062Natural Science Foundation of Fujian Province 2013N0039the CAS/SAFEA International Partnership Program for Creative Research Teams 30973567the High-Level Entrepreneurship and Innovation Talents Projects in Fujian Province 2018-8-1

Figures(2)

At present, the development of antineoplastic drugs has been highly concerned. Many strategies have been developed to explore the safety and effectiveness of antitumor drugs. In recent years, the progress of structural analysis of tumor-associated proteins provides a solid foundation for the design of new targeted drugs through efficient prediction and screening technology. In this review, we briefly summarize the research and development of new antitumor drugs based on structure to enhance tumor targeting property and reduce side effects.
- structure,
- drug design,
- antitumor
1. [1]
  Prakash, G.; Hodnett, E. M. Discriminant analysis and structure-activity relationships. 1. Naphthoquinones. J. Med. Chem. 1978, 21, 369–374. doi: 10.1021/jm00202a011
2. [2]
  Bartkowiak, J.; Kapuscinski, J.; Melamed, M. R.; Darzynkiewicz, Z. Selective displacement of nuclear proteins by antitumor drugs having affinity for nucleic acids. Proc. Natl. Acad. Sci. U. S. A 1989, 86, 5151–5154. doi: 10.1073/pnas.86.13.5151
3. [3]
  Zhang, S. R.; Wang, X. Y.; Guo, Z. J. Rational design of anticancer platinum(Ⅳ) prodrugs. Adv. Inorg. Chem. 2020, 75, 149–182.
4. [4]
  Yang, W. Q.; Chen, X.; Li, Y. L.; Guo, S. F.; Wang, Z.; Yu, X. L. Advances in pharmacological activities of terpenoids. Nat. Prod. Commun. 2020, 15, 1–3.
5. [5]
  Wu, Y.; Huang, R.; Jin, J. M.; Zhang, L. J.; Zhang, H.; Chen, H. Z.; Chen, L. L.; Luan, X. Advances in the study of structural modification and biological activities of anoplin. Front. Chem. 2020, 8, 00519. doi: 10.3389/fchem.2020.00519
6. [6]
  Koike, K.; Nagano, M.; Ebihara, M.; Hirayama, T.; Tsuji, M.; Suga, H.; Nagasawa, H. Design, synthesis, and conformation-activity study of unnatural bridged bicyclic depsipeptides as highly potent hypoxia inducible factor-1 inhibitors and antitumor agents. J. Med. Chem. 2020, 63, 4022–4046. doi: 10.1021/acs.jmedchem.9b02039
7. [7]
  Sengupta, P.; Chattopadhyay, S.; Chatterjee, S. G-Quadruplex surveillance in BCL-2 gene: a promising therapeutic intervention in cancer treatment. Drug Discov. Today 2017, 22, 1165–1186. doi: 10.1016/j.drudis.2017.05.001
8. [8]
  Dallavalle, S.; Dobricic, V.; Lazzarato, L.; Gazzano, E.; Machuqueiro, M.; Pajeva, I.; Tsakovska, I.; Zidar, N.; Fruttero, R. Improvement of conventional anti-cancer drugs as new tools against multidrug resistant tumors. Drug Resist. Update 2020, 50, 100682. doi: 10.1016/j.drup.2020.100682
9. [9]
  Cascioferro, S.; Parrino, B.; Spano, V.; Carbone, A.; Montalbano, A.; Barraja, P.; Diana, P.; Cirrincione, G. 1, 3, 5-Triazines: a promising scaffold for anticancer drugs development. Eur. J. Med. Chem. 2017, 142, 523–549. doi: 10.1016/j.ejmech.2017.09.035
10. [10]
  Zhang, J. M.; Yang, P. L.; Gray, N. S. Targeting cancer with small molecule kinase inhibitors. Nat. Rev. Cancer. 2009, 9, 28–39. doi: 10.1038/nrc2559
11. [11]
  Feucht, J.; Sun, J.; Eyquem, J.; Ho, Y. J.; Zhao, Z. G.; Leibold, J.; Dobrin, A.; Cabriolu, A.; Hamieh, M.; Sadelain, M. Calibration of CAR activation potential directs alternative T cell fates and therapeutic potency. Nat. Med. 2019, 25, 82–88. doi: 10.1038/s41591-018-0290-5
12. [12]
  Landini, I.; Massai, L.; Cirri, D.; Gamberi, T.; Paoli, P.; Messori, L.; Mini, E.; Nobili, S. Structure-activity relationships in a series of auranofin analogues showing remarkable antiproliferative properties. J. Inorg. Biochem. 2020, 208, 111079. doi: 10.1016/j.jinorgbio.2020.111079
13. [13]
  Yamanaka, S.; Sato, Y.; Oikawa, D.; Goto, E.; Fukai, S.; Tokunaga, F.; Takahashi, H.; Sawasaki, T. Subquinocin, a small molecule inhibitor of CYLD and USP-family deubiquitinating enzymes, promotes NF-kappaB signaling. Biochem. Biophys. Res. Commun. 2020, 524, 1–7. doi: 10.1016/j.bbrc.2019.12.049
14. [14]
  Wang, X.; Tan, Y.; Huang, Z.; Huang, N.; Gao, M.; Zhou, F.; Hu, J.; Feng, W. Disrupting myddosome assembly in diffuse large Bcell lymphoma cells using the MYD88 dimerization inhibitor ST2825. Oncol. Rep. 2019, 42, 1755–1766.
15. [15]
  Zhang, L.; Li, Y.; Wang, Q.; Chen, Z.; Li, X.; Wu, Z.; Hu, C.; Liao, D.; Zhang, W.; Chen, Z. S. The PI3K subunits, P110alpha and P110beta are potential targets for overcoming P-gp and BCRP-mediated MDR in cancer. Mol. Cancer. 2020, 19, 10. doi: 10.1186/s12943-019-1112-1
16. [16]
  Lu, S.; Qiu, Y.; Ni, D.; He, X.; Pu, J.; Zhang, J. Emergence of allosteric drug-resistance mutations: new challenges for allosteric drug discovery. Drug. Discov. Today 2020, 25, 177–184. doi: 10.1016/j.drudis.2019.10.006
17. [17]
  Huang, Z.; Zhao, J.; Deng, W.; Chen, Y.; Shang, J.; Song, K.; Zhang, L.; Wang, C.; Lu, S.; Yang, X.; He, B.; Min, J.; Hu, H.; Tan, M.; Xu, J.; Zhang, Q.; Zhong, J.; Sun, X.; Mao, Z.; Lin, H.; Xiao, M.; Chin, Y. E.; Jiang, H.; Xu, Y.; Chen, G.; Zhang, J. Identification of a cellularly active SIRT6 allosteric activator. Nat. Chem. Biol. 2018, 14, 1118–1126. doi: 10.1038/s41589-018-0150-0
18. [18]
  Lin, Y.; Chen, Z.; Hu, C.; Chen, Z. S.; Zhang, L. Recent progress in antitumor functions of the intracellular antibodies. Drug. Discov. Today 2020, 25, 1109–1120. doi: 10.1016/j.drudis.2020.02.009
19. [19]
  Liu, J.; Chen, Z.; Huang, M.; Tang, S.; Wang, Q.; Hu, P.; Gupta, P.; Ashby, C. R.; Chen, Z. S.; Zhang, L. Plasminogen activator inhibitor (PAI) trap3, an exocellular peptide inhibitor of PAI-1, attenuates the rearrangement of F-actin and migration of cancer cells. Exp. Cell. Res. 2020, 391, 111987. doi: 10.1016/j.yexcr.2020.111987
20. [20]
  Polizzi, N. F.; DeGrado, W. F. A defined structural unit enables de novo design of small-molecule-binding proteins. Science 2020, 369, 1227–1233. doi: 10.1126/science.abb8330
21. [21]
  Fuglestad, B.; Marques, B. S.; Jorge, C.; Kerstetter, N. E.; Valentine, K. G.; Wand, A. J. Reverse micelle encapsulation of proteins for nmr spectroscopy. Methods Enzymol. 2019, 615, 43–75.
22. [22]
  Tabata, S.; Jevtic, M.; Kurashige, N.; Fuchida, H.; Kido, M.; Tani, K.; Zenmyo, N.; Uchinomiya, S.; Harada, H.; Itakura, M.; Hamachi, I.; Shigemoto, R.; Ojida, A. Electron microscopic detection of single membrane proteins by a specific chemical labeling. iScience 2019, 22, 256–268. doi: 10.1016/j.isci.2019.11.025
23. [23]
  Glasgow, A. A.; Huang, Y. M.; Mandell, D. J.; Thompson, M.; Ritterson, R.; Loshbaugh, A. L.; Pellegrino, J.; Krivacic, C.; Pache, R. A.; Barlow, K. A.; Ollikainen, N.; Jeon, D.; Kelly, M. J. S.; Fraser, J. S.; Kortemme, T. Computational design of a modular protein sense-response system. Science 2019, 366, 1024–1028. doi: 10.1126/science.aax8780
24. [24]
  Liu, C.; Zhou, H.; Sheng, X. B.; Liu, X. H.; Chen, F. H. Design, synthesis and SARs of novel telomerase inhibitors based on BIBR1532. Bioorg. Chem. 2020, 102, 104077. doi: 10.1016/j.bioorg.2020.104077
25. [25]
  Jeffrey, J. L.; Lawson, K. V.; Powers, J. P. Targeting metabolism of extracellular nucleotides via inhibition of ectonucleotidases CD73 and CD39. J. Med. Chem. 2020. doi: 10.1021/acs.jmedchem.0c01044 (In press). doi: 10.1021/acs.jmedchem.0c01044
26. [26]
  Kang, C. H.; Choi, S. U.; Son, Y. H.; Lee, H. K.; Jeong, H. G.; Yun, C. S.; Ahn, S.; Park, C. H. Discovery of a novel chemical scaffold against mutant isocitrate dehydrogenase 1 (IDH1). Anticancer Res. 2020, 40, 4929–4935.
27. [27]
  Grillo, I. B.; Urquiza-Carvalho, G. A.; Rocha, G. B. PRIMoRDiA: a software to explore reactivity and electronic structure in large biomolecules. J. Chem. Inf. Model. 2020. doi: 10.1021/acs.jcim.0c00655 (In press). doi: 10.1021/acs.jcim.0c00655
28. [28]
  Wang, S.; Hu, X.; Feng, Z.; Liu, L.; Sun, K.; Xu, S. Recognition of ion ligand binding sites based on amino acid features with the fusion of energy, physicochemical and structural features. Curr. Pharm. Des. 2020. doi: 10.2174/1381612826666201029100636 (In press). doi: 10.2174/1381612826666201029100636
29. [29]
  Waldmann, H.; Hart, P.; Hommen, P.; Noisier, A.; Krzyzanowski, A.; Schuler, D.; Porfetye, A. T.; Akbarzadeh, M.; Vetter, I. R.; Adihou, H. Structure based design of bicyclic peptide inhibitors of RbAp48. Angew. Chem. Int. Ed. Engl. 2020. doi: 10.1002/anie.202009749 (In press). doi: 10.1002/anie.202009749
30. [30]
  Kalirajan, R.; Pandiselvi, A.; Gowramma, B.; Balachandran, P. In-silico design, ADMET screening, MM-GBSA binding free energy of some novel isoxazole substituted 9-anilinoacridines as HER2 inhibitors targeting breast cancer. Curr. Drug. Res. Rev. 2019, 11, 118–128.
31. [31]
  Farnaby, W.; Koegl, M.; Roy, M. J.; Whitworth, C.; Diers, E.; Trainor, N.; Zollman, D.; Steurer, S.; Karolyi-Oezguer, J.; Riedmueller, C.; Gmaschitz, T.; Wachter, J.; Dank, C.; Galant, M.; Sharps, B.; Rumpel, K.; Traxler, E.; Gerstberger, T.; Schnitzer, R.; Petermann, O.; Greb, P.; Weinstabl, H.; Bader, G.; Zoephel, A.; Weiss-Puxbaum, A.; Ehrenhofer-Wolfer, K.; Wohrle, S.; Boehmelt, G.; Rinnenthal, J.; Arnhof, H.; Wiechens, N.; Wu, M. Y.; Owen-Hughes, T.; Ettmayer, P.; Pearson, M.; McConnell, D. B.; Ciulli, A. BAF complex vulnerabilities in cancer demonstrated via structure-based PROTAC design. Nat. Chem. Biol. 2019, 15, 672–680.
32. [32]
  Xie, X.; Liu, J.; Wang, X. Design, synthesis and biological evaluation of (2΄, 5΄ and 3΄, 5΄-Linked) cGAMP analogs that activate stimulator of interferon Genes (STING). Molecules 2020, 25.
33. [33]
  Yang, H.; Yan, R.; Jiang, Y.; Yang, Z.; Zhang, X.; Zhou, M.; Wu, X.; Zhang, T.; Zhang, J. Design, synthesis and biological evaluation of 2-amino-4-(1, 2, 4-triazol)pyridine derivatives as potent EGFR inhibitors to overcome TKI-resistance. Eur. J. Med. Chem. 2020, 187, 111966.
34. [34]
  Yang, C. X.; Xing, L.; Chang, X.; Zhou, T. J.; Bi, Y. Y.; Yu, Z. Q.; Zhang, Z. Q.; Jiang, H. L. Synergistic platinum(Ⅱ) prodrug nanoparticles for enhanced breast cancer therapy. Mol. Pharm. 2020, 17, 1300–1309.
1. [1]
  Maitri Bhattacharjee , Rekha Boruah Smriti , R. N. Dutta Purkayastha , Waldemar Maniukiewicz , Shubhamoy Chowdhury , Debasish Maiti , Tamanna Akhtar . Synthesis, structural characterization, bio-activity, and density functional theory calculation on Cu(Ⅱ) complexes with hydrazone-based Schiff base ligands. Chinese Journal of Inorganic Chemistry, 2024, 40(7): 1409-1422. doi: 10.11862/CJIC.20240007
2. [2]
  Peng ZHOU , Xiao CAI , Qingxiang MA , Xu LIU . Effects of Cu doping on the structure and optical properties of Au₁₁(dppf)₄Cl₂ nanocluster. Chinese Journal of Inorganic Chemistry, 2024, 40(7): 1254-1260. doi: 10.11862/CJIC.20240047
3. [3]
  Xiao SANG , Qi LIU , Jianping LANG . Synthesis, structure, and fluorescence properties of Zn(Ⅱ) coordination polymers containing tetra-alkenylpyridine ligands. Chinese Journal of Inorganic Chemistry, 2024, 40(11): 2124-2132. doi: 10.11862/CJIC.20240158
4. [4]
  Xin Dong , Tianqi Chen , Jing Liang , Lei Wang , Huajie Wu , Zhijin Xu , Junhua Luo , Li-Na Li . Structure design of lead-free chiral-polar perovskites for sensitive self-powered X-ray detection. Chinese Journal of Structural Chemistry, 2024, 43(6): 100256-100256. doi: 10.1016/j.cjsc.2024.100256
5. [5]
  Jian Song , Shenghui Wang , Qiuge Liu , Xiao Wang , Shuo Yuan , Hongmin Liu , Saiyang Zhang . N-Benzyl arylamide derivatives as novel and potent tubulin polymerization inhibitors against gastric cancers: Design, structure–activity relationships and biological evaluations. Chinese Chemical Letters, 2025, 36(2): 109678-. doi: 10.1016/j.cclet.2024.109678
6. [6]
  Jing Zhang , Charles Wang , Yaoyao Zhang , Haining Xia , Yujuan Wang , Kun Ma , Junfeng Wang . Application of magnetotactic bacteria as engineering microrobots: Higher delivery efficiency of antitumor medicine. Chinese Chemical Letters, 2024, 35(10): 109420-. doi: 10.1016/j.cclet.2023.109420
7. [7]
  Jin Wang , Xiaoyan Pan , Junyu Zhang , Qingqing Zhang , Yanchen Li , Weiwei Guo , Jie Zhang . Active molecule-based theranostic agents for tumor vasculature normalization and antitumor efficacy. Chinese Chemical Letters, 2024, 35(8): 109187-. doi: 10.1016/j.cclet.2023.109187
8. [8]
  Zhaomin Tang , Qian He , Jianren Zhou , Shuang Yan , Li Jiang , Yudong Wang , Chenxing Yao , Huangzhao Wei , Keda Yang , Jiajia Wang . Active-transporting of charge-reversal Cu(Ⅱ)-doped mesoporous silica nanoagents for antitumor chemo/chemodynamic therapy. Chinese Chemical Letters, 2024, 35(7): 109742-. doi: 10.1016/j.cclet.2024.109742
9. [9]
  Hong-Tao Ji , Yu-Han Lu , Yan-Ting Liu , Yu-Lin Huang , Jiang-Feng Tian , Feng Liu , Yan-Yan Zeng , Hai-Yan Yang , Yong-Hong Zhang , Wei-Min He . Nd@C₃N₄-photoredox/chlorine dual catalyzed synthesis and evaluation of antitumor activities of 4-alkylated sulfonyl ketimines. Chinese Chemical Letters, 2025, 36(2): 110568-. doi: 10.1016/j.cclet.2024.110568
10. [10]
  Chao Ma , Cong Lin , Jian Li . MicroED as a powerful technique for the structure determination of complex porous materials. Chinese Journal of Structural Chemistry, 2024, 43(3): 100209-100209. doi: 10.1016/j.cjsc.2023.100209
11. [11]
  Yuhang Li , Yang Ling , Yanhang Ma . Application of three-dimensional electron diffraction in structure determination of zeolites. Chinese Journal of Structural Chemistry, 2024, 43(4): 100237-100237. doi: 10.1016/j.cjsc.2024.100237
12. [12]
  Hai-Ling Wang , Zhong-Hong Zhu , Hua-Hong Zou . Structure and assembly mechanism of high-nuclear lanthanide-oxo clusters. Chinese Journal of Structural Chemistry, 2024, 43(9): 100372-100372. doi: 10.1016/j.cjsc.2024.100372
13. [13]
  Jie Ma , Jianxiang Wang , Jianhua Yuan , Xiao Liu , Yun Yang , Fei Yu . The regulating strategy of hierarchical structure and acidity in zeolites and application of gas adsorption: A review. Chinese Chemical Letters, 2024, 35(11): 109693-. doi: 10.1016/j.cclet.2024.109693
14. [14]
  Teng-Yu Huang , Junliang Sun , De-Xian Wang , Qi-Qiang Wang . Recent progress in chiral zeolites: Structure, synthesis, characterization and applications. Chinese Chemical Letters, 2024, 35(12): 109758-. doi: 10.1016/j.cclet.2024.109758
15. [15]
  Guilong Li , Wenbo Ma , Jialing Zhou , Caiqin Wu , Chenling Yao , Huan Zeng , Jian Wang . A composite hydrogel with porous and homogeneous structure for efficient osmotic energy conversion. Chinese Chemical Letters, 2025, 36(2): 110449-. doi: 10.1016/j.cclet.2024.110449
16. [16]
  Run-Han Li , Tian-Yi Dang , Wei Guan , Jiang Liu , Ya-Qian Lan , Zhong-Min Su . Evolution exploration and structure prediction of Keggin-type group IVB metal-oxo clusters. Chinese Chemical Letters, 2024, 35(5): 108805-. doi: 10.1016/j.cclet.2023.108805
17. [17]
  Zhengzheng LIU , Pengyun ZHANG , Chengri WANG , Shengli HUANG , Guoyu YANG . Synthesis, structure, and electrochemical properties of a sandwich-type {Co₆}-cluster-added germanotungstate. Chinese Journal of Inorganic Chemistry, 2024, 40(6): 1173-1179. doi: 10.11862/CJIC.20240039
18. [18]
  Xiaoxia WANG , Ya'nan GUO , Feng SU , Chun HAN , Long SUN . Synthesis, structure, and electrocatalytic oxygen reduction reaction properties of metal antimony-based chalcogenide clusters. Chinese Journal of Inorganic Chemistry, 2024, 40(6): 1201-1208. doi: 10.11862/CJIC.20230478
19. [19]
  Shiqi Peng , Yongfang Rao , Tan Li , Yufei Zhang , Jun-ji Cao , Shuncheng Lee , Yu Huang . Regulating the electronic structure of Ir single atoms by ZrO₂ nanoparticles for enhanced catalytic oxidation of formaldehyde at room temperature. Chinese Chemical Letters, 2024, 35(7): 109219-. doi: 10.1016/j.cclet.2023.109219
20. [20]
  Tiantian Li , Ruochen Jin , Bin Wu , Dongming Lan , Yunjian Ma , Yonghua Wang . A novel insight of enhancing the hydrogen peroxide tolerance of unspecific peroxygenase from Daldinia caldariorum based on structure. Chinese Chemical Letters, 2024, 35(4): 108701-. doi: 10.1016/j.cclet.2023.108701

Get Citation

PDF

XML

Metrics

PDF Downloads(5)
Abstract views(400)
HTML views(10)

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142